Product Comparison

Comparison Options

• Print
• Email
• Export Compare

McKesson #	1178025	772707	944706	742745	874309
Description	DURYSTA™ Bimatoprost 10 mcg Intracameral Implant 1 Implant	Latanoprost 0.005%, 50 mcg / mL Solution 2.5 mL	Latisse® Bimatoprost 0.03% Solution 5 mL	Lumigan® Bimatoprost 0.01% Solution 2.5 mL	Latisse® Bimatoprost 0.03% Solution 3 mL
Manufacturer #	00023965201	59762033302	00023361605	00023320503	00023361670
Brand	DURYSTA™		Latisse®	Lumigan®	Latisse®
Manufacturer	Allergan Pharmaceutical	Greenstone Limited	Allergan Pharmaceutical	Allergan Pharmaceutical	Allergan Pharmaceutical
Invoice	DURYSTA, SNGL-USE APPL 10MCG D/S (2EA MIN)	LATANOPROST, DRP 125MCG/2.5ML 2.5ML	LATISSE, DRP OPHTH W/APPL 0.03% 5ML 9ALGN	LUMIGAN, DRP OPHTH 0.01% 2.5MLL 9ALGN	LATISSE, DRP OPHTH W/APPL 0.03% 3ML 9ALGN
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	1550896	1805308	1425909	1893080	2067767
Container Type	Single-Use Applicator	Dropper Bottle	Dropper Bottle	Dropper Bottle	Dropper Bottle
Dosage Form	Intracameral Implant	Solution	Solution	Solution	Solution
Generic Drug Code		32749	16219	27131	16219
Generic Drug Name	Bimatoprost	Latanoprost	Bimatoprost	Bimatoprost	Bimatoprost
NDC Number	00023965201	59762033302	00023361605	00023320503	00023361670
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days
Quantity	1 Implant
Storage Requirements	Requires Refrigeration	Requires Refrigeration
Strength	10 mcg	0.005%, 50 mcg / mL	0.03%	0.01%	0.03%
UNSPSC Code	51241103	51241110	51241103	51241103	51241103
Volume		2.5 mL	5 mL	2.5 mL	3 mL
Application	Prostaglandin Analog	Prostaglandin Analog	Prostaglandin Analog	Prostaglandin Analog	Prostaglandin Analog
Country of Origin	Unknown	Unknown	Unknown	Unknown	Unknown
Type	Ophthalmic	Ophthalmic	Ophthalmic	Ophthalmic	Ophthalmic
Features and Benefits	DURYSTA is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT) DURYSTA contains a 10 mcg bimatoprost intracameral implant in a single-use applicator that is packaged in a sealed foil pouch containing desiccant For ophthalmic intracameral administration	Latanoprost is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension	Topical eyelash solution with 140 applicators	LUMIGAN® is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours	Topical eyelash solution with 70 applicators